LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Surrozen (NASDAQ: SRZN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SRZN Surrozen
COLUMN GROUP III GP, LP / 10 percent owner
11/13/2025
Buy
$12.65
167,307
$2.116M
962,718
NASDAQ SRZN Surrozen
COLUMN GROUP III GP, LP / 10 percent owner
11/13/2025
Buy
$12.65
148,150
$1.874M
852,482
NASDAQ SRZN Surrozen
Maleki Andrew Pedrum / officer: Chief Financial Officer
11/12/2025
Buy
$12.94
50,000
$647K
50,000